Science AI Journal
Biochemistry, Genetics and Molecular Biology · Research topic

Open research questions in Histone Deacetylase Inhibitors Research

96 gap statements mined from Histone Deacetylase Inhibitors Research papers in our 4.5M-paper local library, which holds 363 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

What the literature leaves open

  • The paper identifies challenges in the clinical implementation of marine-derived microtubule-targeting agents, including limited natural abundance, structural complexity, and manufacturing constraints. It highlights the need for advances in synthetic biology, semi-synthesis, and antibody-drug conjugate technology to overcome these limitations. The review emphasizes the importance of addressing these challenges to translate the potential of natural products into clinically viable therapeutics.

    Natural Products as Promising Pharmacological Agents Against Cancer: A Holistic Overview of Their Anti-Cancer Mechanisms of Action of the Last Five Years · 2026 · DOI

  • Limited natural abundance, - Structural complexity, - Manufacturing constraints, particularly for large macrolides such as discodermolide and zampanolide, - Total synthesis strategies are often lengthy and low-yielding, thereby limiting clinical scalability

    Natural Products as Promising Pharmacological Agents Against Cancer: A Holistic Overview of Their Anti-Cancer Mechanisms of Action of the Last Five Years · 2026 · DOI

  • Whether stress-adaptive acetyl-group metabolism contributes to this resistance remains unclear.

    CRAT-mediated acetylcarnitine shuttling sustains p65 acetylation and NF-κB-associated radioresistance in colorectal cancer · 2026 · DOI

  • Nevertheless, the mechanism(s) underlying the synergistic anti-cancer effect remains to be investigated.

    Synergistic Anti-Cancer Activities of Curcumin Derivative CU17 Combined with Gemcitabine Against A549 Non-Small-Cell Lung Cancer Cells · 2025 · DOI

  • Among these, the function and mechanism of SPANXB1 in breast cancer brain metastasis (BCBM) remain poorly understood.

    SPANXB1 drives brain metastasis in breast cancer via MMP1 regulation: potential therapeutic insights with metformin · 2025 · DOI

  • Despite the described function of LSD1 in skeletal muscle differentiation and regeneration, the role of RCOR family in myogenesis remains unknown.

    RCOR1 promotes myoblast differentiation and muscle regeneration · 2025 · DOI

  • Metastatic cancer is a major cause of cancer-related mortality; however, the complex regulation process remains to be further elucidated.

    A glimpse into novel acylations and their emerging role in regulating cancer metastasis · 2024 · DOI

  • Lysine deacetylase inhibitors (KDACis) are approved drugs for cutaneous T cell lymphoma (CTCL), peripheral T cell lymphoma (PTCL), and multiple myeloma, but many aspects of their cellular mechanism of action (MoA) and substantial toxicity are not well understood.

    Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics · 2024 · DOI

  • However, the precise role of histone acetylation in mechanosensing and transduction remains elusive due to the complexity of the acetylation network.

    Deciphering the dynamics: Exploring the impact of mechanical forces on histone acetylation · 2024 · DOI

  • Preventive treatments for peritoneal inflammation and fibrosis are currently lacking.

    Protective effect of Cyclo(His‐Pro) on peritoneal fibrosis through regulation of HDAC3 expression · 2024 · DOI

  • Cyclo(His-Pro) (CHP), a naturally occurring cyclic dipeptide, has demonstrated protective effects in various fibrotic diseases, yet its potential role in peritoneal fibrosis (PF) remains uncertain.

    Protective effect of Cyclo(His‐Pro) on peritoneal fibrosis through regulation of HDAC3 expression · 2024 · DOI

  • However, the regulatory effects of microbial-derived enzymes on the intestinal microbiota composition and the influence on host health remain elusive.

    Xylanase enhances gut microbiota-derived butyrate to exert immune-protective effects in a histone deacetylase-dependent manner · 2024 · DOI

  • CRC tumors are typically associated with a highly immunosuppressive microenvironment. The development of therapeutic strategies to overcome resistance to immunotherapy in CRC is challenging. There is a need to identify novel therapeutic targets to enhance the efficacy of PD-1/PD-L1 blockade immunotherapy.

    G3BP2-K76 acetylation promotes tumor immunoescape by stabilizing PD-L1 expression in colorectal cancer · 2026 · DOI

  • Further studies are needed to investigate the clinical relevance and therapeutic potential of targeting G3BP2-K76 acetylation in CRC. The development of novel therapeutic strategies to target G3BP2-K76 acetylation may provide a promising approach to enhance the efficacy of PD-1/PD-L1 blockade immunotherapy.

    G3BP2-K76 acetylation promotes tumor immunoescape by stabilizing PD-L1 expression in colorectal cancer · 2026 · DOI

  • current therapeutic agents do not reverse the fundamental molecular lesions that initiate and sustain insulin resistance and progressive pancreatic betacell deterioration

    Beyond cancer: the case for natural product-derived dual DNMT1/HDAC3 modulators in diabetic epigenetic therapy and the need for DFT-guided computational refinement · 2026 · DOI

  • The study is based on computational methods and does not include experimental validation. The study only evaluates a limited number of quinazoline analogues. The study does not provide a detailed analysis of the potential side effects of the inhibitors.

    Computational investigation of dual HDAC and VEGFR2 inhibitors using DFT, QSAR and molecular dynamics for rational anticancer drug design · 2026 · DOI

  • Experimental validation of the potential of Compound 20 as a dual inhibitor. Further optimization of the structure of Compound 20 to improve its potency and selectivity. Evaluation of the potential of other quinazoline analogues as dual inhibitors.

    Computational investigation of dual HDAC and VEGFR2 inhibitors using DFT, QSAR and molecular dynamics for rational anticancer drug design · 2026 · DOI

  • Further mechanistic studies are needed to investigate the role of AADAC in PDAC. Clinical trials are needed to evaluate the therapeutic potential of targeting AADAC in PDAC.

    Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer · 2026 · DOI

  • Further investigation of the significant scaffolds identified in the study. Development of new HDAC6 inhibitors based on the identified scaffolds. Experimental validation of the predicted HDAC6 inhibitory activity.

    An integrated machine learning and chemical space network approach for the design of potent epigenetic HDAC6 inhibitors for targeting neurological disorders · 2026 · DOI

  • The lack of effective in vivo activity of HDAC6 inhibitors in neurological disease models. The need for high-quality ML-based classification frameworks for identifying pivotal structural fingerprints of HDAC6 inhibitors.

    An integrated machine learning and chemical space network approach for the design of potent epigenetic HDAC6 inhibitors for targeting neurological disorders · 2026 · DOI

  • Parasite drug resistance is a significant challenge in malaria eradication. The lack of broadly applicable and highly effective vaccines for malaria is a challenge. Variations in prediction algorithms and training datasets can lead to differences in predicted transmembrane topology.

    Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria · 2026 · DOI

  • Investigations of hydroxamic acids as drug leads for malaria and other parasitic diseases, - Further analysis of antiplasmodial structure‐activity relationships, - Guiding investigations of this chemotype as drug leads

    Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria · 2026 · DOI

  • The complexity of HCC pathogenesis. The limited understanding of the role of HDAC6 in HCC. The need for novel therapeutic strategies for HCC.

    Integrative Bioinformatic Characterization of the HDAC6-Driven Cytoskeleton–Wnt Signaling Interface in Hepatocellular Carcinoma: Implications for Immune Modulation and Therapeutic Targeting · 2026 · DOI

  • the residual impact on normal cells remains relevant, - requires careful consideration in the context of therapeutic translation, - the study does not provide a comprehensive analysis of the adaptive logic of cancer

    Special Issue “Novel Therapeutic Targets in Cancers: 3rd Edition” · 2026 · DOI

  • integrative strategies capable of linking experimental biology, computational modeling, and clinical translation, - understanding and disrupting the adaptive logic that sustains malignancy, - exploring the role of membrane lipid remodeling in tumor persistence and therapeutic resistance

    Special Issue “Novel Therapeutic Targets in Cancers: 3rd Edition” · 2026 · DOI

Most-cited papers in Histone Deacetylase Inhibitors Research

Most recent work

Find a gap in your own Histone Deacetylase Inhibitors Research sub-topic

This page shows what the Histone Deacetylase Inhibitors Research literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Biochemistry, Genetics and Molecular Biology

Gut microbiota and health
2,424 open questions
Single-cell and spatial transcriptomics
866 open questions
Extracellular vesicles in disease
765 open questions
Antibiotic Resistance in Bacteria
689 open questions
Genetic Associations and Epidemiology
626 open questions
RNA modifications and cancer
601 open questions
Inflammatory Bowel Disease
543 open questions
Inflammasome and immune disorders
521 open questions
96 gap statements have been mined from Histone Deacetylase Inhibitors Research papers in our 4.5M-paper local library, which holds 363 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? Acceptance odds for top, mid and open/emerging journals, in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck for prior publication across 7 sources and our local library.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.